Quantitative MRS study of Baló's concentric sclerosis lesions

Magnetic Resonance Imaging

Volumn 25, Issue 7, 2007, Pages 1112-1115

  Khiat, Abdesslem ^a   Lesage, Jacques ^a   Boulanger, Yvan ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Bal 's concentric sclerosis; Demyelinating diseases; Diffuse cerebral sclerosis of Schilder; Magnetic resonance spectroscopy

Indexed keywords

CHOLINE; CREATINE; CREATINE PHOSPHATE; DEXAMETHASONE; GLUTAMIC ACID; GLUTAMINE; INOSITOL; LACTIC ACID; LIPID; METHYLPREDNISOLONE SODIUM SUCCINATE; N ACETYLASPARTIC ACID;

ADULT; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DYSARTHRIA; FEMALE; HEMIPARESIS; HUMAN; HYPESTHESIA; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PARESTHESIA; PELIZAEUS MERZBACHER DISEASE; PRIORITY JOURNAL; SYMPTOM;

ADULT; DIAGNOSIS, DIFFERENTIAL; DIFFUSE CEREBRAL SCLEROSIS OF SCHILDER; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MIDDLE AGED;

EID: 34547767999     PISSN: 0730725X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mri.2006.11.005     Document Type: Article

References (17)

1. Siva A., and Kantarci O. An introduction to the clinical spectrum of inflammatory demyelinating disorders of the central nervous system. In: Siva A., Kesselring J., and Thompson A.J. (Eds). Frontiers in multiple sclerosis. 2nd ed. (1999), Martin Dunitz Ltd, London 1-9
2. Chen C.J., Chu N.S., Lu C.S., and Sung C.Y. Serial magnetic resonance imaging in patients with Baló's concentric sclerosis: natural history of lesion development. Ann Neurol 46 (1999) 651-656
3. Kim M.O., Lee S.A., Choi C.G., Huh J.R., and Lee M.C. Baló's concentric sclerosis: a clinical case study of brain MRI, biopsy, and proton magnetic resonance spectroscopic findings. J Neurol Neurosurg Psychiatry 62 (1997) 655-658
4. Ng S.H., Ko S.F., Cheung Y.C., Wong H.F., and Wan Y.L. MRI features of Baló's concentric sclerosis. Br J Radiol 72 (1999) 400-403
5. Chen C.-J. Serial proton magnetic resonance spectroscopy in lesions of Baló concentric sclerosis. Neuroradiology 25 (2001) 713-718
6. Karaarslan E., Altintas A., Senol U., Yeni N., Dincer A., Bayindir C., et al. Baló's concentric sclerosis: clinical and radiologic features of five cases. AJNR Am J Neuroradiol 22 (2001) 1362-1367
7. Bruneteau G., Guillevin R., Tourbah A., Papeix C., Chiras J., and Pierrot-Deseilligny C. Intérêt de la spectroscopie par résonance magnétique dans la sclérose concentrique de Baló. Rev Neurol (Paris) 161 (2005) 455-458
8. Provencher S.W. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 30 (1993) 672-679
9. Frahm J., and Hanefeld F. Localized proton magnetic resonance spectroscopy of brain disorders in childhood. In: Bachelard H.S. (Ed). Magnetic resonance spectroscopy and imaging in neurochemistry (1997), Plenum, New York 329-402
10. Richards T.L. Proton MR spectroscopy in multiple sclerosis: value in establishing diagnosis, monitoring progression, and evaluating therapy. AJR Am J Roentgenol 157 (1991) 1073-1078
11. Roser W., Hagberg G., Mader I., Brunnschweiler H., Radue E.W., Seelig J., et al. Proton MRS of gadolinium-enhancing MS plaques and metabolic changes in normal-appearing white matter. Magn Reson Med 33 (1995) 811-817
12. Davie C.A., Hawkins C.P., Barker G.J., Brennan A., Tofts P.S., Miller D.H., et al. Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. Brain 117 (1994) 49-58
13. Hirsch J.A., Lenkinski R.E., and Grossman R.I. MR spectroscopy in the evaluation of enhancing lesions in the brain in multiple sclerosis. AJNR Am J Neuroradiol 17 (1996) 1829-1936
14. Srinivasan R., Sailasuta N., Hurd R., Nelson S., and Pelletier D. Evidence of elevated glutamate in multiple sclerosis using magnetic resonance spectroscopy at 3 T. Brain 128 (2005) 1016-1025
15. Tedeschi G., and Bonavita S. MR spectroscopy in demyelination and inflammation. In: Gillard J., Waldman A., and Barker P. (Eds). Clinical MR neuroimaging. Diffusion, perfusion and spectroscopy (2005), Cambridge University Press, New York 429-441
16. Fernando K.T.M., McLean M.A., Chard D.T., MacManus D.G., Dalton C.M., Miszkiel K.A., et al. Elevated white matter myo-inositol in clinically isolated syndromes suggestive of multiple sclerosis. Brain 127 (2004) 1361-1369
17. Sastre-Garriga J., Ingle G.T., Chard D.T., Ramio-Torrenta L., McLean M.A., Miller D.H., et al. Metabolite changes in normal-appearing gray and white matter are linked with disability in early primary progressive multiple sclerosis. Arch Neurol 62 (2005) 569-573